Search Course Outline
Showing 25 course outlines from 2713 matches
751
MEDSCI 315
: Nutrition, Diet and Gene Interactions2022 Semester One (1223)
Gene-X environment interactions are increasingly being recognised to play an important role in the risk and pathogenesis of various diseases. The interaction between genetics and dietary factors in modulating mechanism of gut, bone, cancer and metabolic disease will be considered in this course, as well as the technologies required to understand such interactions.
Prerequisite: BIOSCI 202 or 203
752
MEDSCI 315
: Nutrition, Diet and Gene Interactions2021 Semester One (1213)
Gene-X environment interactions are increasingly being recognised to play an important role in the risk and pathogenesis of various diseases. The interaction between genetics and dietary factors in modulating mechanism of gut, bone, cancer and metabolic disease will be considered in this course, as well as the technologies required to understand such interactions.
Prerequisite: BIOSCI 202 or 203
753
MEDSCI 315
: Nutrition, Diet and Gene Interactions2020 Semester One (1203)
Focuses on the importance of nutrition in health and disease from a clinical perspective. The contribution of genetic and epigenetic factors and dietary influences in the development of a range of disorders will be considered. The course is structured using themes that include technologies, gut and metabolism, inflammation, nervous system, mobility and population health.
Prerequisite: BIOSCI 202, 203
754
MEDSCI 316
: Sensory Neuroscience: From Molecules to Disease2025 Semester One (1253)
The physiology of neurosensory systems in health and disease with an emphasis on clinical relevance and current advances in research. The course will provide in-depth coverage of mechanisms involved in each system at a broad systemic level, down to the molecular level. Topics include vision, hearing, balance, olfaction, taste, touch and pain.
Prerequisite: MEDSCI 206
755
MEDSCI 316
: Sensory Neuroscience: From Molecules to Disease2024 Semester One (1243)
The physiology of neurosensory systems in health and disease with an emphasis on clinical relevance and current advances in research. The course will provide in-depth coverage of mechanisms involved in each system at a broad systemic level, down to the molecular level. Topics include vision, hearing, balance, olfaction, taste, touch and pain.
Prerequisite: MEDSCI 206
756
MEDSCI 316
: Sensory Neuroscience: From Molecules to Disease2023 Semester One (1233)
The physiology of neurosensory systems in health and disease with an emphasis on clinical relevance and current advances in research. The course will provide in-depth coverage of mechanisms involved in each system at a broad systemic level, down to the molecular level. Topics include vision, hearing, balance, olfaction, taste, touch and pain.
Prerequisite: MEDSCI 206
757
MEDSCI 316
: Sensory Neuroscience: From Molecules to Disease2022 Semester One (1223)
The physiology of neurosensory systems in health and disease with an emphasis on clinical relevance and current advances in research. The course will provide in-depth coverage of mechanisms involved in each system at a broad systemic level, down to the molecular level. Topics include vision, hearing, balance, olfaction, taste, touch and pain.
Prerequisite: MEDSCI 206
758
MEDSCI 316
: Sensory Neuroscience: From Molecules to Disease2021 Semester One (1213)
The physiology of neurosensory systems in health and disease with an emphasis on clinical relevance and current advances in research. The course will provide in-depth coverage of mechanisms involved in each system at a broad systemic level, down to the molecular level. Topics include vision, hearing, balance, olfaction, taste, touch and pain.
Prerequisite: MEDSCI 206
759
MEDSCI 316
: Sensory Neuroscience: From Molecules to Disease2020 Semester One (1203)
The physiology of neurosensory systems in health and disease with an emphasis on clinical relevance and current advances in research. The course will provide in-depth coverage of mechanisms involved in each system at a broad systemic level, down to the molecular level. Topics include vision, hearing, balance, olfaction, taste, touch and pain.
Prerequisite: MEDSCI 206
760
MEDSCI 317
: Integrative Neuroscience: From Fetus to Adult2025 Semester Two (1255)
The development and function of the central nervous system in health and disease. Topics include development of the CNS, synaptic function in health and disease, development and pathophysiology of motor systems, perinatal and adult brain ischemia and neuroprotection, stroke, chronobiology/human circadian rhythm and olfactory dysfunction during dementia, Parkinson's and Alzheimer's disease. The objective of this course is to provide an overview of the development and function of the central nervous system in health and disease. The course explores the anatomy and physiology of the brain during development into adulthood, and highlights the pathologies of various central nervous system disorders.
Prerequisite: MEDSCI 206
761
MEDSCI 317
: Integrative Neuroscience: From Fetus to Adult2024 Semester Two (1245)
The development and function of the central nervous system in health and disease. Topics include development of the CNS, functional imaging of the human brain, synaptic function in health and disease, development and pathophysiology of motor systems, perinatal and adult brain ischemia, stroke, and sleep related disorders. The topics are covered at an advanced level with emphasis on current advances in the fields.
Prerequisite: MEDSCI 206
762
MEDSCI 317
: Integrative Neuroscience: From Fetus to Adult2023 Semester Two (1235)
The development and function of the central nervous system in health and disease. Topics include development of the CNS, functional imaging of the human brain, synaptic function in health and disease, development and pathophysiology of motor systems, perinatal and adult brain ischemia, stroke, and sleep related disorders. The topics are covered at an advanced level with emphasis on current advances in the fields.
Prerequisite: MEDSCI 206
763
MEDSCI 317
: Integrative Neuroscience: From Fetus to Adult2022 Semester Two (1225)
The development and function of the central nervous system in health and disease. Topics include development of the CNS, functional imaging of the human brain, synaptic function in health and disease, development and pathophysiology of motor systems, perinatal and adult brain ischemia, stroke, and sleep related disorders. The topics are covered at an advanced level with emphasis on current advances in the fields.
Prerequisite: MEDSCI 206
764
MEDSCI 317
: Integrative Neuroscience: From Fetus to Adult2021 Semester Two (1215)
The development and function of the central nervous system in health and disease. Topics include development of the CNS, functional imaging of the human brain, synaptic function in health and disease, development and pathophysiology of motor systems, perinatal and adult brain ischemia, stroke, and sleep related disorders. The topics are covered at an advanced level with emphasis on current advances in the fields.
Prerequisite: MEDSCI 206
765
MEDSCI 317
: Integrative Neuroscience: From Fetus to Adult2020 Semester Two (1205)
The development and function of the central nervous system in health and disease. Topics include development of the CNS, functional imaging of the human brain, synaptic function in health and disease, development and pathophysiology of motor systems, perinatal and adult brain ischemia, stroke, and sleep related disorders. The topics are covered at an advanced level with emphasis on current advances in the fields.
Prerequisite: MEDSCI 206
766
MEDSCI 318
: Pharmacokinetics and Drug Toxicity2025 Semester One (1253)
Considers the biochemical processes involved in achieving clinically-relevant drug concentrations that result in therapeutic effects and drug toxicity, from drug input, distribution, and elimination plus the ways in which these processes are described (pharmacokinetic modelling). Explores factors such as drug-drug interactions, pharmacogenetics, dosing and pharmacokinetic considerations in selected populations and that may influence both clinical effectiveness and drug toxicity.
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 303, 306, 321
Restriction: MEDSCI 303, 306, 321
767
MEDSCI 318
: Pharmacokinetics and Drug Toxicity2024 Semester One (1243)
Considers the biochemical processes involved in achieving clinically-relevant drug concentrations that result in therapeutic effects and drug toxicity, from drug input, distribution, and elimination plus the ways in which these processes are described (pharmacokinetic modelling). Explores factors such as drug-drug interactions, pharmacogenetics, dosing and pharmacokinetic considerations in selected populations and that may influence both clinical effectiveness and drug toxicity.
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 303, 306, 321
Restriction: MEDSCI 303, 306, 321
768
MEDSCI 318
: Pharmacokinetics and Drug Toxicity2023 Semester One (1233)
Considers the biochemical processes involved in achieving clinically-relevant drug concentrations that result in therapeutic effects and drug toxicity, from drug input, distribution, and elimination plus the ways in which these processes are described (pharmacokinetic modelling). Explores factors such as drug-drug interactions, pharmacogenetics, dosing and pharmacokinetic considerations in selected populations and that may influence both clinical effectiveness and drug toxicity.
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 303, 306, 321
Restriction: MEDSCI 303, 306, 321
769
MEDSCI 318
: Pharmacokinetics and Drug Toxicity2022 Semester One (1223)
Considers the biochemical processes involved in achieving clinically-relevant drug concentrations that result in therapeutic effects and drug toxicity, from drug input, distribution, and elimination plus the ways in which these processes are described (pharmacokinetic modelling). Explores factors such as drug-drug interactions, pharmacogenetics, dosing and pharmacokinetic considerations in selected populations and that may influence both clinical effectiveness and drug toxicity.
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 303, 306, 321
Restriction: MEDSCI 303, 306, 321
770
MEDSCI 318
: Pharmacokinetics and Drug Toxicity2021 Semester One (1213)
Considers the biochemical processes involved in achieving clinically-relevant drug concentrations that result in therapeutic effects and drug toxicity, from drug input, distribution, and elimination plus the ways in which these processes are described (pharmacokinetic modelling). Explores factors such as drug-drug interactions, pharmacogenetics, dosing and pharmacokinetic considerations in selected populations and that may influence both clinical effectiveness and drug toxicity.
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 303, 306, 321
Restriction: MEDSCI 303, 306, 321
771
MEDSCI 319
: Molecular Pharmacology2025 Semester One (1253)
Explores the cellular and molecular mechanisms of drug action with a focus on G-protein coupled receptors and biochemical targets for cancer therapy. Drug design is considered from the perspective of in silico modelling, biochemical assessment and intracellular signalling.
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 304, 321
Restriction: MEDSCI 304, 321
772
MEDSCI 319
: Molecular Pharmacology2024 Semester One (1243)
Explores the cellular and molecular mechanisms of drug action with a focus on G-protein coupled receptors and biochemical targets for cancer therapy. Drug design is considered from the perspective of in silico modelling, biochemical assessment and intracellular signalling.
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 304, 321
Restriction: MEDSCI 304, 321
773
MEDSCI 319
: Molecular Pharmacology2023 Semester One (1233)
Explores the cellular and molecular mechanisms of drug action with a focus on G-protein coupled receptors and biochemical targets for cancer therapy. Drug design is considered from the perspective of in silico modelling, biochemical assessment and intracellular signalling.
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 304, 321
Restriction: MEDSCI 304, 321
774
MEDSCI 319
: Molecular Pharmacology2022 Semester One (1223)
Explores the cellular and molecular mechanisms of drug action with a focus on G-protein coupled receptors and biochemical targets for cancer therapy. Drug design is considered from the perspective of in silico modelling, biochemical assessment and intracellular signalling.
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 304, 321
Restriction: MEDSCI 304, 321
775
MEDSCI 319
: Molecular Pharmacology2021 Semester One (1213)
Explores the cellular and molecular mechanisms of drug action with a focus on G-protein coupled receptors and biochemical targets for cancer therapy. Drug design is considered from the perspective of in silico modelling, biochemical assessment and intracellular signalling.
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 304, 321
Restriction: MEDSCI 304, 321
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109